Negative pressure wound therapy (NPWT, often called a wound VAC) applies controlled suction through a sealed dressing. It can help selected complex wounds manage drainage and develop granulation tissue, but it is not automatically better than modern dressings for every wound. Choice depends on wound type, perfusion, infection control, goals, tolerance, and the clinician's assessment.
A wound VAC uses a pump, foam or gauze interface, tubing, and an adhesive seal to maintain prescribed negative pressure. Standard care may use foam, alginate, hydrofiber, collagen, antimicrobial, or other dressings selected for moisture balance and wound-bed needs.
Clinicians may consider NPWT for appropriately debrided wounds with substantial drainage, deep tissue loss, undermining, or a need to encourage granulation. Evidence and expected benefit vary by wound cause; adequate blood flow and a plan to address pressure, infection, and nutrition remain essential.
Modern dressings may be more practical for shallow wounds, low drainage, fragile surrounding skin, comfort-focused care, or wounds that are progressing with simpler treatment. Untreated necrosis, unexplored fistulas, exposed unprotected organs, and some bleeding risks require special caution or may make NPWT inappropriate.
Medicare and other insurers may cover NPWT only when medical-necessity, prior-treatment, wound, and documentation criteria are met. Pump and supply rules, authorization, network status, deductibles, and cost sharing vary by plan; an order or authorization is not a guarantee of payment. A clinician should document measurements, response, dressing frequency, and a stop or transition plan.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.